Shefali Pappu
Obstetrics & Gynecology · Richardson, TXNPI 1528445947
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 37 manufacturers reported payments, led by AbbVie at 24.2% of the total. Reporting peaked in 2022 at $679 and has fallen 61.0% since, to $265 in 2024.
Across 139 payments — averaging $18.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$627
- Organon$175
- Johnson & Johnson$151
- Millicent US Inc$137
- Pfizer$135
- Exeltis, USA Inc.$132
- plus $1K from 31 others
What the payments were for
- Food & beverage$2,56099%
- Education$331%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $627 |
| Organon | 9 | $175 |
| Johnson & Johnson | 5 | $151 |
| Millicent US Inc | 7 | $137 |
| Pfizer | 6 | $135 |
| Exeltis, USA Inc. | 7 | $132 |
| Astellas Pharma US Inc | 6 | $126 |
| Therapeuticsmd, Inc. | 8 | $115 |
| Bayer | 5 | $98 |
| Agile Therapeutics, Inc. | 5 | $81 |
| Myovant Sciences Inc. | 3 | $71 |
| Merck | 5 | $68 |
| Mayne Pharma Commercial LLC | 2 | $51 |
| Conmed Corporation | 1 | $50 |
| Avion Pharmaceuticals | 3 | $50 |
| Virtus Pharmaceuticals LLC | 2 | $42 |
| Innovation Technologies Inc | 1 | $37 |
| Minerva Surgical, Inc | 2 | $36 |
| Pacira Pharmaceuticals Incorporated | 2 | $35 |
| Potrero Medical, Inc. | 1 | $34 |
| Integra Lifesciences Corporation | 2 | $34 |
| AMAG Pharmaceuticals, Inc. | 2 | $33 |
| Evofem Biosciences, Inc. | 2 | $28 |
| LSI Solutions Inc | 1 | $25 |
| Baxter Healthcare | 1 | $24 |
| Medtronic | 1 | $21 |
| Vertical Pharmaceuticals, LLC | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Mylan Pharmaceuticals Inc. | 1 | $19 |
| Zyla Life Sciences, Inc. | 1 | $17 |
| BD | 1 | $17 |
| Duchesnay USA Incorporated | 1 | $16 |
| Channel Medsystems, Inc. | 2 | $16 |
| TELA Bio, Inc. | 1 | $14 |
| Boston Scientific | 1 | $14 |
| Smith+Nephew | 1 | $13 |
| Lupin Inc. | 1 | $11 |
How this compares
$2,592 in reported general payments places this provider in the 70th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 24 | $715 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Richardson
- William SalterRichardson$48K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.